--Alexandria Real Estate Equities Raises Quarterly Dividend to $1.30 a Share, Payable July 15 to Stockholders of Record June 28-June 2024-www.financetom.com

--Alexandria Real Estate Equities Raises Quarterly Dividend to $1.30 a Share, Payable July 15 to Stockholders of Record June 28

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Alexandria Real Estate Equities Raises Quarterly Dividend to $1.30 a Share, Payable July 15 to Stockholders of Record June 28

Jun 3, 2024 8:55 AM

11:34 AM EDT, 06/03/2024 (MT Newswires) --

Price: 118.65, Change: -0.35, Percent Change: -0.29

Previous page： Nippon Steel's Mori returns to US this week for talks on US Steel takeover Next page： --Alexandria Real Estate Equities Raises Quarterly Dividend to $1.30 a Share, Payable July 15 to Stockholders of Record June 28

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Nippon Steel's Mori returns to US this week for talks on US Steel takeover

Jun 3, 2024

TOKYO (Reuters) - Nippon Steel's vice chairman plans to return to the United States this week for more talks over the proposed acquisition of U.S. Steel and would study selling some assets if necessary for the deal to go through. Vice Chairman Takahiro Mori's visit so soon after a May 20-26 trip highlights the efforts Nippon Steel is taking to...

--Alexandria Real Estate Equities Raises Quarterly Dividend to $1.30 a Share, Payable July 15 to Stockholders of Record June 28

Jun 3, 2024

11:34 AM EDT, 06/03/2024 (MT Newswires) -- Price: 118.65, Change: -0.35, Percent Change: -0.29 ...

Why Microbot Medical Stock Is Up

Jun 3, 2024

Microbot Medical Inc. ( MBOT ) shares are trading higher Monday after the company announced that it has received FDA approval to proceed with its human clinical trial as part of its Investigational Device Exemption (IDE) application for its LIBERTY Endovascular Robotic Surgical System. The Details: Microbot said the study will be conducted in the U.S., and it has already...

Why Intellia Therapeutics Shares Are Trading Higher Monday

Jun 3, 2024

Intellia Therapeutics, Inc. ( NTLA ) stock is moving higher Monday after the company announced long-term data from its Phase 1 Study of NTLA-2002. The Details: Intellia’s NTLA-2002 is an experimental CRISPR based gene-editing therapy being developed as a one-time treatment for hereditary angioedema (HAE). The company announced the single dose treatment led to a 98% mean reduction in monthly...